Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience.

Sio TT, Wilson ZC, Stauder MC, Bhatia S, Martenson JA, Quevedo JF, Schomas DA, Miller RC.

Am J Clin Oncol. 2016 Oct;39(5):448-52. doi: 10.1097/COC.0000000000000089.

PMID:
24879469
2.

Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.

Zanoni A, Verlato G, Giacopuzzi S, Weindelmayer J, Casella F, Pasini F, Zhao E, de Manzoni G.

Ann Surg Oncol. 2013 Jun;20(6):1993-9. doi: 10.1245/s10434-012-2822-4. Epub 2012 Dec 29.

PMID:
23274533
3.

Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.

Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.

Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23.

PMID:
24854492
4.

Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.

Nomura M, Oze I, Kodaira T, Abe T, Komori A, Narita Y, Masuishi T, Taniguchi H, Kadowaki S, Ura T, Andoh M, Tachibana H, Uemura N, Tajika M, Niwa Y, Muto M, Muro K.

Int J Clin Oncol. 2016 Oct;21(5):890-898. Epub 2016 Mar 15.

PMID:
26980212
5.

Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer.

Chang KJ, Reid T, Senzer N, Swisher S, Pinto H, Hanna N, Chak A, Soetikno R.

Gastrointest Endosc. 2012 Jun;75(6):1139-46.e2. doi: 10.1016/j.gie.2012.01.042. Epub 2012 Apr 18.

6.

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

Kersting S, Konopke R, Dittert D, Distler M, Rückert F, Gastmeier J, Baretton GB, Saeger HD.

J Gastroenterol Hepatol. 2009 May;24(5):886-95.

7.

Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.

Hategan M, Cook N, Prewett S, Hindmarsh A, Qian W, Gilligan D.

Dis Esophagus. 2015 Oct;28(7):612-8. doi: 10.1111/dote.12242. Epub 2014 May 27. Review.

PMID:
24863560
8.

Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.

Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M.

Radiology. 1999 Oct;213(1):67-72.

PMID:
10540642
9.

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, Song HY, Cho KJ, Kim WK, Lee JS, Kim SH, Min YI.

Ann Oncol. 2004 Jun;15(6):947-54.

PMID:
15151953
10.

Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.

Wang J, Suri JS, Allen PK, Liao Z, Komaki R, Ho L, Hofstetter WL, Lin SH.

Am J Clin Oncol. 2016 Jun;39(3):228-35. doi: 10.1097/COC.0000000000000066.

PMID:
24710122
11.

[Esophageal cancer: outcome according to therapeutic strategy].

Rousseau D, Capitain O, Denis F, Girault S, Poirier AL, Paumier A, Cellier P, Hamy A, Mahé MA, Mesgouez-Nebout N.

Cancer Radiother. 2013 Feb;17(1):10-20. doi: 10.1016/j.canrad.2012.10.011. Epub 2012 Dec 25. French.

PMID:
23270680
12.

Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.

Kushida T, Nohara S, Yoshino K, Fujiwara D, Ouchi K, Amano T, Isayama F, Tomita N, Iwanuma Y, Sasai K, Tsurumaru M, Kajiyama Y.

Dis Esophagus. 2014 May-Jun;27(4):368-73. doi: 10.1111/dote.12105. Epub 2013 Jul 19.

PMID:
23865505
13.

Nonsurgical management of esophageal adenocarcinoma.

Gujral DM, Hawkins MA, Leonulli BG, Ashley S, Chau I, Cunningham D, Tait D.

Clin Colorectal Cancer. 2011 Sep;10(3):165-70. doi: 10.1016/j.clcc.2011.03.017. Epub 2011 Apr 28.

PMID:
21855037
14.

Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.

Smit JK, Güler S, Beukema JC, Mul VE, Burgerhof JG, Hospers GA, Plukker JT.

Ann Surg Oncol. 2013 Nov;20(12):4008-15. doi: 10.1245/s10434-013-3102-7. Epub 2013 Jul 10.

PMID:
23838922
15.

Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma.

Chen WH, Chao YK, Chang HK, Tseng CK, Wu YC, Liu YH, Hsieh MJ, Liu HP.

Dis Esophagus. 2012 Apr;25(3):250-5. doi: 10.1111/j.1442-2050.2011.01243.x. Epub 2011 Sep 23.

PMID:
21951719
16.

[Long-term outcome of neoadjuvant radiochemotherapy followed by surgery for esophageal cancer: a single institution retrospective study of 102 patients].

Ruffier-Loubière A, Janoray G, Chapet S, de Calan L, Dumont P, Dorval É, Orain I, Calais G.

Cancer Radiother. 2015 Aug;19(5):322-30. doi: 10.1016/j.canrad.2015.04.004. Epub 2015 Jul 26. French.

PMID:
26215366
17.

Impact of radiotherapy, chemotherapy and surgery in multimodal treatment of locally advanced esophageal cancer.

Berger B, Stahlberg K, Lemminger A, Bleif M, Belka C, Bamberg M.

Oncology. 2011;81(5-6):387-94. doi: 10.1159/000335263. Epub 2012 Jan 20.

PMID:
22269965
18.

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.

Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.

Ann Surg Oncol. 2008 Oct;15(10):2894-902. doi: 10.1245/s10434-008-0084-y. Epub 2008 Jul 29.

PMID:
18663531
19.

Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Jeong Y, Kim JH, Kim SB, Yoon DH, Park SI, Kim YH, Kim HR, Jung HY, Lee GH, Ryu JS.

J Surg Oncol. 2014 Apr;109(5):472-7. doi: 10.1002/jso.23514. Epub 2013 Dec 2.

PMID:
24301552
20.

Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?

Tougeron D, Scotté M, Hamidou H, Di Fiore F, Paillot B, Michot F, Michel P.

J Surg Oncol. 2012 Jun 15;105(8):761-6. doi: 10.1002/jso.22157. Epub 2011 Nov 28.

PMID:
22124932

Supplemental Content

Support Center